TRANSVAC2 offers technical services at all stages of the Vaccine R&D pipeline to support vaccine development 

COVID19 vaccine development projects are encouraged to apply for TRANSVAC2 Services 

Submit your application until April 15th 2020

Open Call:

>>  Fast-track review process for COVID19 applications <<

TRANSVAC: New Vaccines Faster

TRANSVAC is a collaborative infrastructure project funded by the European Commission (EC), initially under the 7th Framework Programme (FP7) and currently under Horizon 2020.  The project is a joint effort of leading European groups working in the field of vaccine development, and is coordinated by the European Vaccine Initiative (EVI). TRANSVAC is designed to accelerate vaccine development by enhancing European vaccine research and training, and increase sustainability of EC vaccine projects by implementing a permanent research infrastructure for early vaccine development.

 OPEN CALL  

Apply for Vaccine Development Services and Training Now!

services at all stages

of the Vaccine R&D Pipeline                 

Free technical & theoretical courses at leading European centres               

SARS-CoV-2 illustration:Centers for Disease Control and Prevention (CDC)  Image by: CDC/ Alissa Eckert, MS; Dan Higgins, MAMS

Support to development of vaccines against COVID19

Researchers developing vaccine candidates against #COVID19 are encouraged to apply and benefit

from all TRANSVAC2 services, such as:
 

   Adjuvant formulation - Vaccine Formulation Institute , Statens Serum Institut and  Helmholtz Centre for Infection Research 
   Structural Biology - INSTRUCT

   Animal models - CEABPRCIRTA-CReSA  and Helmholtz Centre for Infection Research 
   Clinical Trial Support - ECRIN (European Clinical Research Infrastructure Network)
   Regulatory support - EATRIS and European Vaccine Initiative

 Check out all services available here >>>>

You cannot find the services you need?

If the service you require is not among the services currently offered by TRANSVAC2, please contact EATRIS (davidmorrow@eatris.eu) and we can assess it on case by case basis.

For specific inquiries on the details of each service available please contact directly service providers

Eligibility Criteria for COVID19 applications will be less stringent.

COVID19 applications review process will be fast-tracked.

    Consider this

Latest News, events & more...

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 730964.

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N° 730964.

Be the first to know about the upcoming application calls, follow European Vaccine Initiative on:

  • LinkedIn Social Icon
  • Twitter Social Icon

Designed by European Vaccine Initiative